BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16554763)

  • 1. London's disastrous drug trial has serious side effects for research.
    Wadman M
    Nature; 2006 Mar; 440(7083):388-9. PubMed ID: 16554763
    [No Abstract]   [Full Text] [Related]  

  • 2. Drugs tests on trial.
    Nature; 2006 Apr; 440(7087):970. PubMed ID: 16625159
    [No Abstract]   [Full Text] [Related]  

  • 3. Inquiries in Britain uncover loopholes in drug trials.
    Rosenthal E
    N Y Times Web; 2006 Aug; ():A3. PubMed ID: 16909495
    [No Abstract]   [Full Text] [Related]  

  • 4. [Rituximab. A monoclonal CD20 antibody--hematological indications and possible treatments for immunoinflammatory diseases].
    Hansen PB; Hasselbalch HC
    Ugeskr Laeger; 2004 Feb; 166(6):466-9. PubMed ID: 15045710
    [No Abstract]   [Full Text] [Related]  

  • 5. Missing results might have rung warning bell over trial drug.
    Pearson H
    Nature; 2006 Oct; 443(7113):730-1. PubMed ID: 17051171
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug discovery. Magnificent obsession.
    Couzin J
    Science; 2005 Mar; 307(5716):1712-5. PubMed ID: 15774740
    [No Abstract]   [Full Text] [Related]  

  • 7. British rethinking test rules after drug trial nearly kills 6.
    Rosenthal E
    N Y Times Web; 2006 Apr; ():A1, A6. PubMed ID: 16642579
    [No Abstract]   [Full Text] [Related]  

  • 8. Agency criticises drug trial.
    Day M
    BMJ; 2006 Jun; 332(7553):1290. PubMed ID: 16740539
    [No Abstract]   [Full Text] [Related]  

  • 9. [Side effects of a desastrous clinical trial].
    Gilgenkrantz S
    Med Sci (Paris); 2006 May; 22(5):557-8. PubMed ID: 16687128
    [No Abstract]   [Full Text] [Related]  

  • 10. Expect the unexpected.
    Lancet Oncol; 2006 May; 7(5):355. PubMed ID: 16648035
    [No Abstract]   [Full Text] [Related]  

  • 11. High stakes, high risks.
    Lancet Oncol; 2007 Feb; 8(2):85. PubMed ID: 17267317
    [No Abstract]   [Full Text] [Related]  

  • 12. [New catastrophe in pharmacological treatment--the crisis of clinical studies? Acute organ failure after administration of TGN1412].
    Jerie P
    Cas Lek Cesk; 2006; 145(6):426. PubMed ID: 16835991
    [No Abstract]   [Full Text] [Related]  

  • 13. High-risk molecules or insufficient scientific data?
    Mignot A
    Clin Pharmacol Ther; 2008 Feb; 83(2):365-7. PubMed ID: 18091760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Firm involved in drug trial fiasco files for bankruptcy.
    Dyer O
    BMJ; 2006 Jul; 333(7559):114. PubMed ID: 16840457
    [No Abstract]   [Full Text] [Related]  

  • 15. India's drug tests.
    Padma TV
    Nature; 2005 Jul; 436(7050):485. PubMed ID: 16049471
    [No Abstract]   [Full Text] [Related]  

  • 16. Profile: Vera Sharav. Interview by Charlie Schmidt.
    Sharav V
    Nat Biotechnol; 2008 Sep; 26(9):965. PubMed ID: 18779796
    [No Abstract]   [Full Text] [Related]  

  • 17. Cytokine storm and an anti-CD28 monoclonal antibody.
    Gardner K
    N Engl J Med; 2006 Dec; 355(24):2591-2; author reply 2593-4. PubMed ID: 17171819
    [No Abstract]   [Full Text] [Related]  

  • 18. Can super-antibody drugs be tamed?
    Nature; 2006 Apr; 440(7086):855-6. PubMed ID: 16612349
    [No Abstract]   [Full Text] [Related]  

  • 19. [Beliefs, hopes, misbeliefs (connection between the pharmaceutical industry and clinical research)].
    Simon K
    Orv Hetil; 2004 Jun; 145(24):1275-6. PubMed ID: 15264755
    [No Abstract]   [Full Text] [Related]  

  • 20. The Northwick Park tragedy--protecting healthy volunteers in future first-in-man trials.
    Dowsing T; Kendall MJ
    J Clin Pharm Ther; 2007 Jun; 32(3):203-7. PubMed ID: 17489872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.